###begin article-title 0
Species-specific regulation of alternative splicing in the C-terminal region of the p53 tumor suppressor gene
###end article-title 0
###begin p 1
To whom correspondence should be addressed. Tel: +1 819 564 5284; Fax: +1 819 564 5340; Email: alavigue@courrier.usherb.ca The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
###end p 1
###begin p 2
###xml 686 689 686 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 193 199 <span type="species:ncbi:10090">murine</span>
###xml 218 221 <span type="species:ncbi:10116">rat</span>
###xml 225 230 <span type="species:ncbi:9606">human</span>
###xml 549 552 <span type="species:ncbi:10116">rat</span>
###xml 611 616 <span type="species:ncbi:10090">mouse</span>
###xml 621 624 <span type="species:ncbi:10116">rat</span>
###xml 791 796 <span type="species:ncbi:9606">human</span>
###xml 933 936 <span type="species:ncbi:10116">rat</span>
###xml 941 946 <span type="species:ncbi:9606">human</span>
Alternative splicing occurs in the C-terminal region of the p53 tumor suppressor gene between two alternative 3' splice sites in intron 10. This alternative splicing event has been detected in murine cells, but not in rat or human tissues. In this paper, we have characterized the pattern of p53 alternative splicing in cell lines from five different species. Our results confirm that p53 alternative splicing is species-specific, being detected only in cell lines of rodent origin. Using transient transfection assays, we have established that the rat p53 gene undergoes efficient alternative splicing in both mouse and rat cell lines, thus demonstrating that it has all the necessary cis-acting sequences to be alternatively spliced. In contrast, we were unable to detect any usage of the human alternative 3' splice site under the same experimental conditions. Thus, the low levels or absence of alternatively spliced p53 mRNA in rat and human cell lines seems to be the result of different mechanisms. Our results support the hypothesis that there are species-specific mechanisms implicated in the regulation of p53 activity.
###end p 2
###begin p 3
DDBJ/EMBL/GenBank accession nos AF190269-AF190272
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c1">1</xref>
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c2">2</xref>
###xml 172 173 172 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 181 182 181 182 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c3">3</xref>
###xml 300 301 300 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c6">6</xref>
###xml 449 450 449 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c7">7</xref>
###xml 451 452 451 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c9">9</xref>
###xml 597 598 597 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c8">8</xref>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c10">10</xref>
###xml 753 754 753 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c5">5</xref>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c11">11</xref>
###xml 820 822 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c13">13</xref>
###xml 873 875 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c14">14</xref>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c15">15</xref>
The p53 tumor suppressor gene plays a very important role in oncogenesis, as it is mutated in nearly 50% of most types of tumors (1,2). The p53 protein is involved in the G1/S and G2/M transitions of the cell cycle, in a pathway responsible for DNA damage repair and in the induction of apoptosis (3-6). After various forms of cellular stress such as DNA damage or hypoxia, p53 protein levels are greatly increased, mainly by protein stabilization (7-9). Following these augmented levels, p53 will send signals to downstream effectors which will ultimately lead to cell cycle arrest or apoptosis (8-10). The p53 protein can positively or negatively regulate the transcription of several cellular genes and binds directly to cellular and viral proteins (5). Furthermore, p53 is able to directly recognize damaged DNA (11-13) and to promote re-annealing of both DNA and RNA (14,15).
###end p 5
###begin p 6
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c6">6</xref>
###xml 778 779 778 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c3">3</xref>
###xml 780 781 780 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c5">5</xref>
###xml 782 783 782 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c6">6</xref>
The p53 protein contains four functional domains, an N-terminal transcriptional activation region (amino acids 1-42), a proline-rich domain (amino acids 61-94) involved in growth suppression and apoptosis, a central sequence-specific DNA-binding domain (amino acids 102-292) and a C-terminal region (amino acids 293-393). The C-terminal region can be subdivided into a flexible linker, a tetramerization domain and a DNA and RNA annealing domain which can also bind single-stranded DNA without any sequence specificity (6). The C-terminal region of p53 plays a direct role in sensing damaged DNA and it has been suggested that this region allosterically regulates p53 DNA-binding activity, possibly by masking the DNA-binding region located in the central part of the molecule (3,5,6).
###end p 6
###begin p 7
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c16">16</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c18">18</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c18">18</xref>
###xml 56 62 <span type="species:ncbi:10090">murine</span>
An alternative splicing event has been described in the murine p53 gene between exon 10 and two alternative 3' splice sites, one located at the border of exon 11 (3'R) and the other (3'Cas) located 96 nt upstream of the regular 3' splice site (16-18). The presence of a stop codon in the 96 nt insert from intron 10 results in production of a protein of 381 residues in which the last 26 amino acids of the regular p53 (p53R) are missing and are replaced by a 17 amino acid sequence of unknown function, unique to the alternatively spliced p53 (p53Cas) (18).
###end p 7
###begin p 8
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c19">19</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c21">21</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c15">15</xref>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c22">22</xref>
###xml 738 740 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c23">23</xref>
###xml 365 371 <span type="species:ncbi:10090">murine</span>
The p53R and p53Cas gene products have distinct biochemical activities and are functionally different. The p53Cas protein has constitutive sequence-specific DNA binding whereas the p53R protein requires activation for efficient DNA binding (19-21). While p53R has RNA and DNA annealing activities, p53Cas lacks these activities (15). It has also been reported that murine p53Cas induces apoptosis in myeloid cells, albeit with kinetics that are different from the p53R isoform (22). Finally, although both p53 isoforms can inhibit growth of cells lacking endogenous p53, endogenous p53R and p53Cas proteins respond to DNA damage with different kinetics of nuclear accumulation and efficiencies of binding to a p53 consensus DNA sequence (23).
###end p 8
###begin p 9
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c17">17</xref>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c18">18</xref>
###xml 245 246 245 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 350 351 350 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c18">18</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c18">18</xref>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c24">24</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c21">21</xref>
###xml 37 43 <span type="species:ncbi:10090">murine</span>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
p53Cas RNA has been detected in both murine cells lines and normal mouse tissues (17,18). Using a p53 antibody specific for the alternatively spliced form of p53, it has been shown that the p53Cas protein is preferentially expressed during the G2 phase of the cell cycle, in contrast to the regular p53 protein, which is preferentially expressed in G1 (18). In addition, p53Cas is differentially expressed in proliferating epidermal cells when compared to differentiating cultures (18) or at different stages of keratinocyte differentiation (24). The timing of p53Cas and p53R RNA and protein synthesis during the cell cycle could be important in p53 biochemical functions which are mediated by interaction between two protein products of the wild-type p53 gene (21). The marked increase in DNA-binding activity of p53Cas relative to p53R implies that a potential mechanism for activating p53 function in a cellular context could be by increasing the relative amount of p53Cas to p53R.
###end p 9
###begin p 10
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c25">25</xref>
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c26">26</xref>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c27">27</xref>
###xml 227 232 <span type="species:ncbi:9606">human</span>
###xml 398 404 <span type="species:ncbi:10090">murine</span>
###xml 409 414 <span type="species:ncbi:9606">human</span>
Recently, a more complex alternative splicing pattern generating four different isoforms in the C-terminal region of p73, a protein having substantial functional and structural similarity to p53, has also been described in the human p73 gene (25,26). Another closely related member of the p53 family, named p63, also exhibits a complex pattern of alternative splicing that is conserved between the murine and human genes in both the N- and C-terminal regions (27).
###end p 10
###begin p 11
###xml 318 321 <span type="species:ncbi:10116">rat</span>
###xml 323 329 <span type="species:ncbi:10090">murine</span>
###xml 334 339 <span type="species:ncbi:9606">human</span>
In this paper, we have characterized the alternative splicing pattern in the C-terminal region of the p53 gene from different cell lines and species and have used transient transfection assays to study the molecular basis for the difference observed in the alternative splicing pattern of the C-terminal region of the rat, murine and human p53 genes.
###end p 11
###begin title 12
MATERIALS AND METHODS
###end title 12
###begin title 13
DNA sequences
###end title 13
###begin p 14
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
###xml 101 104 <span type="species:ncbi:10116">rat</span>
###xml 135 142 <span type="species:ncbi:499232|species:ncbi:9593">gorilla</span>
The DNA sequences have been deposited in GenBank under the following accession nos: mouse, AF190269; rat, AF190270; hamster, AF190271; gorilla, AF190272.
###end p 14
###begin title 15
Cell lines
###end title 15
###begin p 16
###xml 66 72 <span type="species:ncbi:9913">bovine</span>
###xml 397 403 <span type="species:ncbi:9913">bovine</span>
All the cell lines were grown in DMEM supplemented with 10% fetal bovine serum and an antibiotic/antimycotic mix (100 U/ml penicillin G, 100 microg/ml streptomycin, 0.25 microg/ml Fungizone) (Gibco), with the exception of the HeLa cell line, which was grown in RPMI 1640, and the CHO cell line, which was grown in alpha-MEM. Both the RPMI 1640 and alpha-MEM media were supplemented with 10% fetal bovine serum and an antibiotic/antimycotic mix (100 U/ml penicillin G, 100 microg/ml streptomycin, 0.25 microg/ml Fungizone) (Gibco).
###end p 16
###begin title 17
Probes for RNase protection
###end title 17
###begin p 18
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Probe MT7C-E9</italic>
###xml 94 102 94 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c28">28</xref>
###xml 17 23 <span type="species:ncbi:10090">murine</span>
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
Probe MT7C-E9The murine probe MT7C-E9 corresponding to the mouse p53Cas cDNA was generated by in vitro transcription on a PCR template containing the T7 RNA polymerase promoter region (28). The PCR template was generated by amplification of a p53Cas cDNA with oligonucleotides E9S1 (5'-AACCACTTGATGGAGAGTATTTCACC-3') and T7Cas (5'-TAATACGACCACTATAGGGAAGGCTTGGAAGGCTCTAGGCTGGAGG-3'). The p53Cas cDNA was obtained by reverse transcription of cytoplasmic mRNA purified from the N2A cell line.
###end p 18
###begin p 19
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Probe MT7E-E9.</italic>
###xml 94 102 94 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 19 25 <span type="species:ncbi:10090">murine</span>
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
Probe MT7E-E9. The murine probe MT7E-E9 corresponding to the mouse p53R cDNA was generated by in vitro transcription on a PCR template containing the T7 RNA polymerase promoter region (28). The PCR template was generated by amplification of a p53R cDNA with oligonucleotides E9S1 (5'-AACCACTTGATGGAGAGTATTTCACC-3') and T7E11A1 (5'-TAATACGACTCACTATAGGGTCAGTCTGAGTCAGGCCC-3'). The p53R cDNA was obtained by reverse transcription of cytoplasmic mRNA purified from the N2A cell line.
###end p 19
###begin p 20
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Probe HT7E-PuI</italic>
###xml 56 64 56 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c28">28</xref>
###xml 18 23 <span type="species:ncbi:9606">human</span>
Probe HT7E-PuIThe human probe HT7E-PuI was generated by in vitro transcription on a PCR template containing the T7 RNA polymerase promoter region (28). The PCR template was generated by amplification of the plasmid ppip53 with oligonucleotides T7E11A1 (5'-TAATACGACTCACTATAGGGTCAGT- CTGAGTCAGGCCC-3') and HPuInS1 (5'-GGTAAGGGAAGATTACGAGAC-3').
###end p 20
###begin p 21
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Probes Mp53L and Rp53L</italic>
###xml 86 94 86 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 184 187 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nhe</italic>
###xml 199 202 199 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 205 208 205 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nhe</italic>
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
###xml 52 55 <span type="species:ncbi:10116">rat</span>
###xml 224 236 <span type="species:ncbi:10710">phage lambda</span>
###xml 283 287 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Probes Mp53L and Rp53LThe mouse probe Mp53L and the rat probe Rp53L were generated by in vitro transcription with T3 RNA polymerase on plasmids pTEP Mp53L and pTEP Rp53L digested with NheI. A 181 nt BamHI-NheI fragment from phage lambda was inserted between the p53 minigene and the SV40 polyadenylation signal of pTEP Mp53 to generate pTEP Mp53L and of pTEP Rp53 to generate pTEP Rp53L.
###end p 21
###begin p 22
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Probe Hp53B</italic>
###xml 50 58 50 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 131 134 131 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bgl</italic>
###xml 15 20 <span type="species:ncbi:9606">human</span>
Probe Hp53BThe human probe Hp53B was generated by in vitro transcription with T3 RNA polymerase on plasmid pTEP Hp53 digested with BglII.
###end p 22
###begin title 23
RNase protection of endogenous p53 mRNA from cell lines
###end title 23
###begin p 24
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c28">28</xref>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c29">29</xref>
###xml 550 558 534 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 619 621 603 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 652 654 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c28">28</xref>
###xml 231 236 <span type="species:ncbi:10090">mouse</span>
###xml 259 264 <span type="species:ncbi:10090">mouse</span>
###xml 266 269 <span type="species:ncbi:10116">rat</span>
###xml 306 311 <span type="species:ncbi:9606">human</span>
###xml 335 340 <span type="species:ncbi:9606">human</span>
###xml 486 491 <span type="species:ncbi:10090">mouse</span>
###xml 504 509 <span type="species:ncbi:9606">human</span>
Extraction of cytoplasmic RNA was done using the NP40/urea method as described previously (28). RNA hybridization was performed essentially as described previously (29). Hybridization was performed overnight at 55degreesC with the mouse probe MT7C-E9 for the mouse, rat and hamster cell lines and with the human probe HT7E-PuI for the human and monkey cell lines. Following hybridization, the RNA was digested with 50 U of RNase T1 and 0.05 microg of RNase A at 30degreesC for 1 h. The mouse MT7C-E9 and human HT7E-PuI RNA probes were synthesized by in vitro transcription with T7 RNA polymerase and radiolabeled with [32P]UTP as described previously (28).
###end p 24
###begin title 25
RT-PCR analysis of RNA from cell lines
###end title 25
###begin p 26
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c28">28</xref>
###xml 103 106 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
###xml 236 241 <span type="species:ncbi:10090">mouse</span>
###xml 255 258 <span type="species:ncbi:10116">rat</span>
###xml 344 349 <span type="species:ncbi:9606">human</span>
Cytoplasmic RNA from cell lines was extracted by the NP40/urea method (28). Reverse transcription with AMV reverse transcriptase was done at 42degreesC for 30 min, using the E11A7 oligonucleotide primer (5'-ACTTTCTTAGCCATTGTTTT-3') for mouse, hamster and rat cell lines or the MPuA2 oligonucleotide primer (5'-AGACTGGCCCTTCTTGGTCTTCAGG-3') for human and monkey cell lines. Following denaturation at 94degreesC for 1 min, PCR was performed for 30 cycles (94degreesC for 1 min, 65degreesC for 1 min), with a final incubation at 72degreesC for 2 min, using the primers E10S1 (5'-GTCTCGAGCGCTTCGAGATGTTC-3') and MPuA2. PCR products were run on a 5% polyacrylamide gel with 0.5x TBE.
###end p 26
###begin title 27
PCR amplification of the p53 exon 10-exon 11 region
###end title 27
###begin p 28
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c30">30</xref>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 319 324 <span type="species:ncbi:9606">human</span>
###xml 412 417 <span type="species:ncbi:9606">human</span>
###xml 432 437 <span type="species:ncbi:9606">human</span>
###xml 625 632 <span type="species:ncbi:499232|species:ncbi:9593">gorilla</span>
###xml 759 766 <span type="species:ncbi:499232|species:ncbi:9593">gorilla</span>
###xml 971 974 <span type="species:ncbi:10116">rat</span>
###xml 1164 1167 <span type="species:ncbi:10116">rat</span>
The mouse p53 exon 10-exon 11 region was amplified by PCR from plasmid pM53R-18 containing the p53 gene from the CB7 cell line (30) using oligonucleotides E10S1 (5'-GTCTCGAGCGCTTCGAGATGTTC-3') and E11A1 (5'-GGAA- GCTTCAGTCTGAGTCAGG-3'). PCR was performed for 30 cycles (94degreesC for 1 min, 55degreesC for 1 min). The human p53 exon 10-exon 11 region was amplified by PCR from the plasmid ppip53 containing the human p53 gene from human fetal liver (kindly provided by Dr L. Crawford, ICRF, London, UK) using oligonucleotides E10S1and E11A1. PCR was performed for 30 cycles (94degreesC for 1 min, 55degreesC for 1 min). The gorilla p53 exon 10-exon 11 region was amplified by PCR with oligonucleotides E10S3 (5'-TGTTCCGAGAGCTGAATGAGGCCT-3') and E11A1, using gorilla genomic DNA (kindly provided by Dr G. Boissonneault, Universite de Sherbrooke, Sherbrooke, Canada). PCR was performed for 40 cycles (94degreesC for 1 min, 50degreesC for 1 min, 72degreesC for 1 min). The rat p53 exon 10-exon 11 region was amplified by PCR with oligonucleotides E10S4 (5'-CG-CTTCGAGATGTTCCGGGAGCTGAAT-3') and Rp53A1 (5'-GGACTAGCATTGTCTTGTCAGC-3'), using genomic DNA extracted from rat kidneys. PCR was performed for 40 cycles (94degreesC for 1 min, 60degreesC for 1 min, 72degreesC for 1.5 min). The hamster p53 intron 10-exon 11 region was amplified by PCR with oligonucleotides PuIn (5'-GGTGAAAGGGAGGATAAACTGA-3') and E11A1, using genomic DNA extracted from hamster kidneys. PCR was performed for 40 cycles (94degreesC for 1 min, 60degreesC for 1 min, 72degreesC for 1.5 min).
###end p 28
###begin title 29
DNA sequence analysis of PCR products
###end title 29
###begin p 30
###xml 88 90 88 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 153 156 153 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 162 165 162 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 480 483 480 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 489 492 489 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 555 558 555 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 564 567 564 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 737 740 737 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nhe</italic>
###xml 742 745 742 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 924 927 924 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 933 936 933 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 999 1002 999 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 1008 1011 1008 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 1132 1135 1132 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 1138 1141 1138 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 1148 1151 1148 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bgl</italic>
###xml 1154 1157 1154 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 1390 1393 1390 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 1867 1870 1867 1870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 2249 2252 2249 2252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 281 286 <span type="species:ncbi:10090">mouse</span>
###xml 761 766 <span type="species:ncbi:9606">human</span>
###xml 1184 1191 <span type="species:ncbi:499232|species:ncbi:9593">gorilla</span>
###xml 1484 1487 <span type="species:ncbi:10116">rat</span>
###xml 1570 1573 <span type="species:ncbi:10116">rat</span>
All the DNA sequences were determined using a Pharmacia sequencing kit (Pharmacia) and [35S]ATP. Oligonucleotides E10S1 and E11A1 contain, respectively, XhoI and HindIII restriction sites that were used to clone the PCR fragments into the plasmid pBluescript KS+ (Stratagene). The mouse p53 sequence (CB7) was determined from two independent plasmids (pMp53) generated from cloning of DNA fragments derived from two independent PCR reactions. The PCR fragments were digested with XhoI and HindIII and cloned into the plasmid pBluescript KS+ digested with XhoI and HindIII. The sequence was determined using the universal and reverse primers (Pharmacia) with the pMp53 plasmid and a derivative plasmid obtained by deletion of an internal NheI-XbaI fragment. The human p53 sequence was determined from a plasmid (pHp53) generated from cloning of a DNA fragment obtained by PCR. The DNA from the PCR reaction was digested with XhoI and HindIII and cloned into the plasmid pBluescript KS+ digested with XhoI and HindIII. The sequence was determined using the universal and reverse primers with pHp53 and derivative plasmids obtained by EcoRI-EcoRI and BglII-BamHI internal deletions. The gorilla p53 sequence was determined from a plasmid (pGop53) generated from cloning of a DNA fragment obtained by PCR. The DNA from the PCR reaction was cloned into the plasmid pBluescript SK+ digested with EcoRV. The sequence of the 3'-region was determined using the reverse primer with pGop53. The rat p53 sequence was determined by direct cycle sequencing of a PCR reaction from the rat p53 gene with oligonucleotides E10S4 and E11A1 on an Applied Biosystems 373A (University of Calgary Sequencing Services) and also from a plasmid (pRp53) generated from cloning of a DNA fragment obtained by PCR. DNA from the PCR reaction was cloned in the plasmid pBluescript KS+ digested with EcoRV. The sequence was determined using oligonucleotides E10S4 (5'-CGCTTCGAGATGTTCCGGGAGCTGAAT-3'), E11A1 and E11A4 (5'-GATCAAGGCTTGGAAGGCTCTAGGCTGGA-3') with pRp53. The hamster p53 sequence was determined from a plasmid (pHap53) generated from cloning of a DNA fragment obtained by PCR. A DNA fragment from the PCR reaction was cloned in the plasmid pBluescript KS+ digested with EcoRV. The sequence was determined using the universal and reverse primers with pHap53.
###end p 30
###begin title 31
p53 minigene expression vectors and transient transfection assays
###end title 31
###begin p 32
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c31">31</xref>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f5">5</xref>
###xml 569 571 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c28">28</xref>
###xml 684 686 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c29">29</xref>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
###xml 41 44 <span type="species:ncbi:10116">rat</span>
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 167 170 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 216 220 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
The exon 10-exon 11 region of the mouse, rat and human p53 genes were inserted into the pTEP expression vector, a derivative of pCMVSV containing the cytomegalovirus (CMV) promoter region and the poly(A) signal from SV40 virus (kindly provided by Dr B. Chabot, Universite de Sherbrooke, Sherbrooke, Canada) (31). In Figure 5A (lanes 1-3), cells were transfected with 2 microg of plasmid DNA and 4 microl of Fugene (Roche) according to the supplier's recommendations. Cytoplasmic RNA was isolated 48 h after transfection by the NP40/urea method as described previously (28) and RNA samples were subjected to DNase I digestion. RNA hybridization was performed essentially as described (29). Cytoplasmic RNA and the Mp53L probe were hybridized at 50degreesC overnight. RNase digestion was performed with 100 U of RNase T1.
###end p 32
###begin p 33
###xml 10 11 10 11 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f5">5</xref>
###xml 486 487 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f5">5</xref>
###xml 869 870 837 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f5">5</xref>
In Figure 5A (lanes 4 and 5), cells were transfected with 2 microg of plasmid DNA and 4 microl of Fugene (Roche) according to the supplier's recommendations. Cytoplasmic RNA was isolated 24 h after transfection by the NP40/urea method and subjected to DNase I digestion. RNA was hybridized overnight at 50degreesC with the Mp53L probe and digested with 100 U of RNase T1 (lane 4) or with the Hp53B probe and digested with 100 U of RNase T1 and 0.1 microg of RNase A (lane 5). In Figure 5B, cell were transfected with 2 microg of plasmid DNA and 4 microl of Dosper Liposomal Transfection Reagent (Boehringer) according to the supplier's recommendations. Cytoplasmic RNA was isolated 48 h after transfection by the NP40/urea method and treated with DNase I. RNA was hybridized overnight at 50degreesC with the MT7E-E9 probe and digested with 100 U of RNase T1. In Figure 5C, cells were transfected with 2 microg of plasmid DNA and 4 microl of Fugene (Roche). Cytoplasmic RNA was isolated 24 h after transfection by the NP40/urea method and digested with DNase I. RNA was hybridized overnight at 50degreesC with the Mp53L probe (lanes 1 and 2) or with the Rp53L probe (lanes 3 and 4) and digested with 100 U of RNase T1.
###end p 33
###begin title 34
RESULTS
###end title 34
###begin title 35
Analysis of expression of the p53R and p53Cas isoforms in cell lines
###end title 35
###begin p 36
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f1">1</xref>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkd249tb1">1</xref>
###xml 492 493 492 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f2">2</xref>
###xml 1110 1112 1110 1112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1125 1126 1125 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f2">2</xref>
###xml 1303 1304 1303 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f2">2</xref>
###xml 630 636 <span type="species:ncbi:10090">murine</span>
###xml 682 688 <span type="species:ncbi:10090">murine</span>
###xml 870 873 <span type="species:ncbi:10116">rat</span>
###xml 1202 1207 <span type="species:ncbi:9606">human</span>
As a first step in characterization of the alternative splicing event affecting the C-terminal region of the p53 gene (Fig. 1), we analyzed the levels of p53Cas and p53R mRNA in cell lines from five different species. To determine the relative frequency of utilization of the two alternative 3' splice sites of the p53 gene, we analyzed the steady-state levels of mRNA of each type by RNase protection assays and by RT-PCR (Table 1). As shown by the RNase protection assay depicted in Figure 2A, although the ratio p53R:p53Cas varied between cell lines, the alternatively spliced p53 mRNA (p53Cas) was readily detected in all the murine cell lines tested. Quantification of the two murine isoforms by phosphorimaging indicated that p53Cas is expressed at levels varying between 2 and 26% of the p53R mRNA. Analysis of the expression of the two different p53 isoforms in rat cell lines also showed the presence of low (NRK cell line) to very low (FR3T3, IEC6, IEC6ras, NRK and NBTII cell lines) levels of p53Cas in these cell lines using the RNase protection assay or RT-PCR with incorporation of radiolabeled [32P]dCTP (Fig. 2). We were unable to detect any p53Cas in one monkey, two hamster and seven human cell lines despite the fact that we easily detected the p53R isoform in these cell lines (Fig. 2).
###end p 36
###begin title 37
Sequence analysis of the p53 exon 10-exon 11 region from different species
###end title 37
###begin p 38
###xml 220 223 220 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 502 503 502 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f3">3</xref>
###xml 381 387 <span type="species:ncbi:10090">murine</span>
###xml 392 397 <span type="species:ncbi:9606">human</span>
###xml 425 432 <span type="species:ncbi:499232|species:ncbi:9593">gorilla</span>
###xml 446 449 <span type="species:ncbi:10116">rat</span>
To gain a better understanding of the differences observed in the p53R:p53Cas ratio between the different species analyzed above, we first analyzed the DNA sequence of the alternatively spliced p53 region to see whether cis-acting sequences could explain the observed differences. To do so, we amplified by PCR the region between exon 10 and exon 11 from cloned genomic fragments (murine and human p53 genes) or genomic DNA (gorilla, hamster and rat p53 genes) with p53-specific oligonucleotides (Fig. 3).
###end p 38
###begin p 39
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f3">3</xref>
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 148 154 <span type="species:ncbi:10090">murine</span>
###xml 159 162 <span type="species:ncbi:10116">rat</span>
The region between exon 10 and exon 11 of the human p53 gene produced a PCR fragment of 1105 bp compared to PCR fragments of 778 and 884 bp for the murine and rat p53 genes, respectively. The hamster p53 gene was amplified with oligonucleotides located in intron 10 and exon 11 giving an amplification product of 293 nt (Fig. 3 and Materials and Methods).
###end p 39
###begin p 40
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 172 177 <span type="species:ncbi:9606">human</span>
###xml 304 309 <span type="species:ncbi:9606">human</span>
###xml 440 445 <span type="species:ncbi:9606">human</span>
Sequencing of an exon 10-exon 11 PCR fragment amplified from a plasmid containing part of human p53 was done to ensure that the amplified p53 fragment used to generate our human p53 expression vector did not suffer mutations in its 5' and 3' splicing signals during the process of PCR amplification. The human p53 DNA we obtained was shown to have a 5' splice site and 3' splicing signals identical to the splicing signals of the published human p53 gene (GenBank accession nos X54156 and U94788).
###end p 40
###begin p 41
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c30">30</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c16">16</xref>
###xml 765 766 765 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f4">4</xref>
###xml 45 51 <span type="species:ncbi:10090">murine</span>
###xml 144 149 <span type="species:ncbi:10090">mouse</span>
###xml 329 335 <span type="species:ncbi:10090">murine</span>
###xml 648 651 <span type="species:ncbi:10116">rat</span>
###xml 703 710 <span type="species:ncbi:499232|species:ncbi:9593">gorilla</span>
Similarly, we determined the sequence of the murine exon 10-exon 11 region from the erythroleukemic cell line CB7 (30). The DNA sequence of the mouse alternatively spliced 3'-region was found to be identical to the previously published sequence of this region (16). In addition, the sequence of the exon 10-exon 11 region of the murine p53 gene was determined from genomic DNA isolated from the Balb/c cell line. The sequence of the 5' splice site and the alternatively spliced 3'-region of the p53 gene from the CB7 and Balb/c cell lines were found to be identical (M.Laverdiere and A.Lavigueur, unpublished results). The complete DNA sequence of rat p53 intron 10 and the sequences of the hamster and gorilla p53 3'-region of intron 10 were also determined (Fig. 4).
###end p 41
###begin p 42
###xml 725 726 725 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f4">4</xref>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 172 177 <span type="species:ncbi:9606">human</span>
###xml 215 222 <span type="species:ncbi:499232|species:ncbi:9593">gorilla</span>
###xml 457 464 <span type="species:ncbi:499232|species:ncbi:9593">gorilla</span>
###xml 499 505 <span type="species:ncbi:10090">murine</span>
###xml 510 513 <span type="species:ncbi:10116">rat</span>
###xml 647 653 <span type="species:ncbi:10090">murine</span>
###xml 710 713 <span type="species:ncbi:10116">rat</span>
As determined by DNA sequence analysis, the size difference between the human and the rodent p53 genes is due to the presence of an Alu element present in intron 10 of the human gene. While the same region from the gorilla p53 gene was not sequenced completely, the size of the PCR amplification fragment (~1100 bp) and the very close evolutionary distance between these two species is consistent with the presence of an Alu element in intron 10 of the p53 gorilla gene. One peculiar feature of the murine and rat p53 genes is the presence of TGA/G triplet repeats in intron 10 of both genes. Two stretches of 10 and 14 triplets were found in the murine gene whereas a stretch of 20 repeats was present in the rat gene (Fig. 4).
###end p 42
###begin p 43
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkd249tb2">2</xref>
###xml 305 306 305 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkd249tb3">3</xref>
###xml 39 45 <span type="species:ncbi:10090">murine</span>
###xml 47 50 <span type="species:ncbi:10116">rat</span>
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 136 142 <span type="species:ncbi:10090">murine</span>
###xml 151 154 <span type="species:ncbi:10116">rat</span>
###xml 224 229 <span type="species:ncbi:10090">mouse</span>
###xml 234 239 <span type="species:ncbi:9606">human</span>
Comparison of the homology between the murine, rat and human p53 intron 10 sequences showed 78% conservation of nucleotides between the murine and the rat gene, whereas only 42% of the nucleotides were identical between the mouse and human p53 intron 10 sequences, excluding the Alu element (Tables 2 and 3).
###end p 43
###begin p 44
###xml 386 387 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f4">4</xref>
###xml 1133 1134 1133 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f4">4</xref>
###xml 227 233 <span type="species:ncbi:10090">murine</span>
###xml 238 241 <span type="species:ncbi:10116">rat</span>
###xml 246 251 <span type="species:ncbi:9606">human</span>
###xml 424 429 <span type="species:ncbi:9606">human</span>
###xml 431 434 <span type="species:ncbi:10116">rat</span>
###xml 439 444 <span type="species:ncbi:10090">mouse</span>
###xml 525 530 <span type="species:ncbi:9606">human</span>
###xml 604 610 <span type="species:ncbi:10090">murine</span>
###xml 615 618 <span type="species:ncbi:10116">rat</span>
###xml 630 635 <span type="species:ncbi:9606">human</span>
###xml 763 769 <span type="species:ncbi:10090">murine</span>
###xml 774 777 <span type="species:ncbi:10116">rat</span>
###xml 891 894 <span type="species:ncbi:10116">rat</span>
###xml 899 905 <span type="species:ncbi:10090">murine</span>
###xml 1026 1031 <span type="species:ncbi:9606">human</span>
The comparison of the 5' and 3' splicing signals of the 3'Cas and the 3'R region among themselves and with consensus sequences revealed some interesting features. Although there was a 1 nt difference at position +3 between the murine and rat and human p53 5' splice site, the exon 10 donor splice site from these three species matched the 5' splice site consensus sequence gtRAGT (Fig. 4). Similarly, the 3'R splice site of human, rat and mouse did not deviate significantly from the consensus 3' splice site Y(n)AG with the human 3'R splice site having a somewhat poorer match to the consensus than the murine and rat genes. The human 3'R polypyrimidine tract has a long stretch of 23 pyrimidines interrupted by two purines at positions -11 and -17, whereas the murine and rat polypyrimidine tracts contain only one purine at position -12. On the other hand, the 3'Cas splice site from the rat and murine genes showed a relatively short polypyrimidine tract of, respectively, 11 and 12 uninterrupted pyrimidines, whereas the human 3'Cas splice site showed a particularly poor pyrimidine stretch interrupted by several purines (Fig. 4).
###end p 44
###begin p 45
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f4">4</xref>
###xml 447 448 447 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f4">4</xref>
###xml 75 82 <span type="species:ncbi:499232|species:ncbi:9593">gorilla</span>
###xml 157 160 <span type="species:ncbi:10116">rat</span>
###xml 165 171 <span type="species:ncbi:10090">murine</span>
###xml 319 326 <span type="species:ncbi:499232|species:ncbi:9593">gorilla</span>
###xml 379 386 <span type="species:ncbi:499232|species:ncbi:9593">gorilla</span>
###xml 404 409 <span type="species:ncbi:9606">human</span>
###xml 552 557 <span type="species:ncbi:9606">human</span>
We also sequenced a region covering the 3' splicing signals of hamster and gorilla p53. The hamster 3' splicing signals showed a very strong homology to the rat and murine p53 counterparts with the only difference being a purine inserted at position -11 of the 3'Cas site (Fig. 4). The sequence of the same region from gorilla showed that there was complete homology between the gorilla sequence and the human gene over the 180 nt shown in Figure 4, indicating that the p53Cas polypyrimidine stretch interrupted by several purines that was detected in human is identical in this closely related species.
###end p 45
###begin p 46
###xml 435 436 435 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f4">4</xref>
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
###xml 75 78 <span type="species:ncbi:10116">rat</span>
###xml 316 321 <span type="species:ncbi:9606">human</span>
###xml 326 333 <span type="species:ncbi:499232|species:ncbi:9593">gorilla</span>
We noted the presence of a fairly good potential branch site in the mouse, rat and hamster p53Cas splice site with the A residue of the branch site consensus sequence (YNYYRAY) located at position -15 from the AG. A potential branch site with complete homology to the branch site consensus sequence was found in the human and gorilla p53Cas site with the A residue located at position -22 from the 3' splice site AG dinucleotide (Fig. 4).
###end p 46
###begin p 47
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c18">18</xref>
###xml 299 302 <span type="species:ncbi:10116">rat</span>
###xml 370 375 <span type="species:ncbi:10090">mouse</span>
###xml 380 383 <span type="species:ncbi:10116">rat</span>
###xml 625 630 <span type="species:ncbi:10090">mouse</span>
###xml 704 709 <span type="species:ncbi:9606">human</span>
###xml 812 817 <span type="species:ncbi:10090">mouse</span>
###xml 837 842 <span type="species:ncbi:9606">human</span>
###xml 948 954 <span type="species:ncbi:10090">murine</span>
It has been reported that the p53Cas mRNA encodes a protein with a stretch of 17 different amino acids in the C-terminal region (LQPRAFQALIKEESPNC) compared to the regular p53 protein (18). Comparison of the translated amino acid sequence in the alternatively spliced region shows that the putative rat peptide (LQPRTFQALIKKESPNC) is very well conserved, since both the mouse and rat regions encode a 17 amino acid peptide with only two amino acid differences. In contrast, the putative Cas-specific protein sequence encoded by the hamster gene comprises only eight amino acids (LHPRAFQT) that show partial homology with the mouse sequence. The hypothetical Cas-specific C-terminal region encoded by the human p53Cas region (LRPFKALVREKGHRPSHSCDVIFPPCFCLLQPPEVQKGSVYLPP) is even more divergent compared with the mouse sequence since the human p53 gene has the potential to encode a C-terminal region of 44 residues showing little homology with the murine sequence.
###end p 47
###begin title 48
Analysis of the relative use of p53 alternative 3' splice sites by transient transfection
###end title 48
###begin p 49
###xml 291 296 291 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 111 116 <span type="species:ncbi:9606">human</span>
###xml 192 195 <span type="species:ncbi:10116">rat</span>
###xml 391 396 <span type="species:ncbi:9606">human</span>
###xml 398 401 <span type="species:ncbi:10116">rat</span>
###xml 406 411 <span type="species:ncbi:10090">mouse</span>
Our analysis of the DNA sequencing data suggests that failure to use the p53Cas alternative splice site in the human gene could be due to its poor 3' splice signal. On the other hand, the p53 rat gene may not use its Cas 3' splice site in spite of a good 3' splicing signal, possibly due to trans-acting factors. We decided to test the splicing potential of the Cas 3' splice sites from the human, rat and mouse p53 genes by transfecting them into cell lines. The p53 splicing pattern was analyzed by RNase protection after transient transfection.
###end p 49
###begin p 50
###xml 19 20 19 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f5">5</xref>
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f5">5</xref>
###xml 551 552 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f5">5</xref>
###xml 671 672 671 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f2">2</xref>
###xml 945 946 945 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f5">5</xref>
###xml 43 49 <span type="species:ncbi:10090">murine</span>
###xml 81 87 <span type="species:ncbi:10090">murine</span>
###xml 484 487 <span type="species:ncbi:10116">rat</span>
###xml 528 534 <span type="species:ncbi:10090">murine</span>
###xml 637 640 <span type="species:ncbi:10116">rat</span>
###xml 724 729 <span type="species:ncbi:9606">human</span>
###xml 794 799 <span type="species:ncbi:9606">human</span>
###xml 879 884 <span type="species:ncbi:9606">human</span>
As shown in Figure 5A, transfection of the murine p53 expression vector into the murine N2A cell line readily led to the detection of exogenous p53Cas and p53R mRNAs. The production of a relatively similar p53Cas:p53R ratio from the transfected expression vector and the endogenous gene indicated that our minigene is sufficient for proper utilization of the 3' alternatively spliced sites (Fig. 5A, lane 2). Also, we detected both p53 mRNAs from the expression vector containing the rat p53 gene when transfected into the same murine cell line (Fig. 5A, lanes 3 and 4), with a proportion of p53Cas mRNA significantly higher than in the rat cell lines analyzed in Figure 2. On the other hand, we were not able to detect any human p53Cas mRNA in the N2A cell line, in spite of the fact that the human p53R mRNA was easily detected, suggesting that the Cas 3' splice site from the human p53 gene is intrinsically very weak or non-functional (Fig. 5A, lane 5).
###end p 50
###begin p 51
###xml 169 170 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f5">5</xref>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 54 60 <span type="species:ncbi:10090">murine</span>
###xml 142 148 <span type="species:ncbi:10090">murine</span>
###xml 268 274 <span type="species:ncbi:10090">murine</span>
We also transfected the Panc human cell line with the murine p53 expression vector. As a transfection control in this experiment, we used the murine N2A cell line (Fig. 5B, lanes 3 and 4). As shown in this figure, we easily detected the p53R and p53Cas mRNAs from the murine p53 expression vector when transfected in both of these cell lines.
###end p 51
###begin p 52
###xml 331 332 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f5">5</xref>
###xml 576 577 576 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f5">5</xref>
###xml 705 706 705 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f2">2</xref>
###xml 1094 1095 1094 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f5">5</xref>
###xml 1201 1202 1201 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f2">2</xref>
###xml 25 28 <span type="species:ncbi:10116">rat</span>
###xml 90 93 <span type="species:ncbi:10116">rat</span>
###xml 223 229 <span type="species:ncbi:10090">murine</span>
###xml 294 297 <span type="species:ncbi:10116">rat</span>
###xml 378 384 <span type="species:ncbi:10090">murine</span>
###xml 663 666 <span type="species:ncbi:10116">rat</span>
###xml 729 732 <span type="species:ncbi:10116">rat</span>
###xml 793 798 <span type="species:ncbi:10090">mouse</span>
###xml 862 865 <span type="species:ncbi:10116">rat</span>
###xml 948 951 <span type="species:ncbi:10116">rat</span>
###xml 1181 1184 <span type="species:ncbi:10116">rat</span>
###xml 1250 1253 <span type="species:ncbi:10116">rat</span>
To test the ability of a rat cell line to use a p53Cas 3' splice site, we transfected two rat cell lines (NBTII and NRK) which both express low levels of endogenous p53Cas mRNA. The NBTII cell line was transfected with the murine p53 minigene whereas the NRK cell line was transfected with the rat p53 minigene. As shown in Figure 5, the p53R and p53Cas mRNAs produced from the murine p53 expression vector were easily detected when transfected into the NBTII cell line. The amount of p53Cas mRNA produced by splicing of the transcript encoded by the transfected vector (Fig. 5C, lane 2) was significantly higher than the p53Cas endogenous level observed in this rat cell line and the CB7 cell line (Fig. 2), suggesting that the rat NBTII cell line can utilize the Cas 3' splice site from the mouse p53 gene. Following transfection of the NRK cell line with the rat p53 minigene, we also easily detected the p53R and p53Cas mRNAs produced from the rat p53 expression vector. Surprisingly, the amount of p53Cas mRNA produced by splicing of the transcript encoded by the transfected vector (Fig. 5C, lane 4) was significantly higher than the p53Cas endogenous level observed in this rat cell line (Fig. 2), suggesting that the low levels of endogenous rat p53Cas mRNA are not simply due to its p53Cas 3' splice site, as suggested by the DNA sequence analysis.
###end p 52
###begin title 53
DISCUSSION
###end title 53
###begin title 54
Analysis of the expression of the p53R and p53Cas isoforms in cell lines
###end title 54
###begin p 55
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c32">32</xref>
###xml 661 664 661 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 711 713 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c33">33</xref>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c37">37</xref>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c38">38</xref>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c49">49</xref>
###xml 199 205 <span type="species:ncbi:10090">murine</span>
###xml 584 590 <span type="species:ncbi:10090">murine</span>
The results we have obtained from RNase protection and RT-PCR analysis of cell lines show a broad variation in the ratio of the p53 isoforms among cell lines and between species. Among the different murine cell lines derived from various tissues that we have analyzed, we have detected the presence of the p53Cas mRNA in all cases, albeit with considerable differences between cell lines. It is possible that these differences are due to the cell type or differentiation state of the cells analyzed. Previously, such tissue-specific variations were also reported from the analysis of murine whole tissues (32). It is also possible that in some cell lines other cis-acting sequences, such as splicing enhancers (33-37) or splicing silencers (38-49), might be mutated in the p53 gene. This possibility is currently being investigated.
###end p 55
###begin p 56
###xml 31 33 31 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c32">32</xref>
###xml 205 206 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f2">2</xref>
###xml 94 97 <span type="species:ncbi:10116">rat</span>
###xml 130 133 <span type="species:ncbi:10116">rat</span>
###xml 710 713 <span type="species:ncbi:10116">rat</span>
Unlike Will and collaborators (32), we have detected small amounts of the p53Cas mRNA in some rat cell lines, indicating that the rat p53Cas 3' splice site is used to some extent in these cell lines (Fig. 2). It is possible that the apparent discrepancy between their results and ours is due to technical differences such as the use of cell lines instead of whole tissues, in the experimental conditions used for the RT or PCR reactions or the amount of starting material. For instance, we used up to 50 microg of total RNA from some cell lines to obtain a good signal from the p53R mRNA, likely reflecting a very low level of p53 mRNA in these cell lines. However, it is clear that the level of p53Cas in the rat samples is indeed relatively low to almost undetectable. The physiological implications, if any, of such low levels of p53Cas mRNA remain to be determined.
###end p 56
###begin p 57
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c17">17</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c32">32</xref>
###xml 64 69 <span type="species:ncbi:9606">human</span>
Our analysis of eight different cell lines derived from various human tissues failed to detect any p53Cas mRNA in spite of the fact that we obtained a strong signal for the p53R mRNA. Similarly, we did not detect any p53Cas mRNA in the CHO or BHK hamster cell lines or the monkey Cos-1 cell line. Thus, based on our results and the results of other groups (17,32), the production of p53Cas mRNA is almost exclusively detected in tissues or cell lines of rodent origin.
###end p 57
###begin title 58
Sequence analysis of the p53 exon 10-exon 11 region from different species
###end title 58
###begin p 59
###xml 168 171 168 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 737 738 737 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f4">4</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 231 236 <span type="species:ncbi:9606">human</span>
###xml 315 320 <span type="species:ncbi:9606">human</span>
###xml 403 409 <span type="species:ncbi:10090">murine</span>
###xml 454 459 <span type="species:ncbi:9606">human</span>
###xml 668 675 <span type="species:ncbi:499232|species:ncbi:9593">gorilla</span>
###xml 716 721 <span type="species:ncbi:9606">human</span>
###xml 792 797 <span type="species:ncbi:9606">human</span>
The human p53 sequence shows that the p53Cas 3' splice site has a poor polypyrimidine tract, suggesting that the lack of p53Cas mRNA might be due, at least in part, to cis-acting sequences. In addition, the reading frame after the human p53Cas splice site is different from the rodent sequences, since the putative human p53Cas peptide is 44 amino acids long and with a sequence very different from its murine counterpart. These results suggest that the human gene has suffered several mutations in the p53Cas region during evolution, leading to inactivation of this 3' splice site and production of the p53R mRNA only. The DNA sequence from the same 3' region of the gorilla p53 gene is completely identical to the human sequence (Fig. 4), indicating that this sequence is not unique to the human p53 gene and making it highly unlikely that a sequencing error or a mutation in the parental ppip53 plasmid is responsible for the sequence differences.
###end p 59
###begin p 60
###xml 127 133 <span type="species:ncbi:10090">murine</span>
###xml 158 163 <span type="species:ncbi:9606">human</span>
###xml 557 563 <span type="species:ncbi:10090">murine</span>
The Cas 3' splice site of the hamster p53 gene may represent an intermediate case, with a polypyrimidine tract poorer than the murine one but better than the human polypyrimidine tract. Although we would expect the hamster Cas 3' splice site to be used rather weakly considering its splice site sequence, the splicing potential of this 3' splice site remains to be established. Utilization of the hamster 3' Cas splice site would lead to a putative hamster p53Cas-specific peptide with only eight amino acid residues that shows only limited homology to its murine counterpart, which has 17 amino acid residues.
###end p 60
###begin p 61
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c50">50</xref>
###xml 957 959 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c32">32</xref>
###xml 33 39 <span type="species:ncbi:10090">murine</span>
###xml 44 47 <span type="species:ncbi:10116">rat</span>
###xml 280 283 <span type="species:ncbi:10116">rat</span>
###xml 381 384 <span type="species:ncbi:10116">rat</span>
###xml 415 418 <span type="species:ncbi:10116">rat</span>
###xml 486 492 <span type="species:ncbi:10090">murine</span>
###xml 584 587 <span type="species:ncbi:10116">rat</span>
###xml 662 668 <span type="species:ncbi:10090">murine</span>
###xml 860 865 <span type="species:ncbi:10090">mouse</span>
###xml 874 877 <span type="species:ncbi:10116">rat</span>
Our DNA sequence analysis of the murine and rat p53 C-terminal region revealed that in spite of nearly identical 5' and 3' splicing signals, these two species use the p53Cas splice site quite differently. On the basis of sequence alone, it seems that the Cas splice site from the rat p53 gene should be functional. Furthermore, translation of the DNA segment encoding the putative rat p53Cas protein shows that the rat p53Cas protein should be identical in its C-terminal region to the murine p53Cas protein with the exception of two residues. These results suggest that although the rat p53 gene has the potential to encode a p53Cas protein very similar to the murine protein, regulation of p53 gene expression is different between these two species. This interpretation is supported by the observation that there are species-specific differences between the mouse and the rat p53 proteins in their phosphorylation (50), as discussed previously by others (32).
###end p 61
###begin p 62
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c51">51</xref>
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c57">57</xref>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c58">58</xref>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c27">27</xref>
###xml 416 421 <span type="species:ncbi:10090">mouse</span>
###xml 426 431 <span type="species:ncbi:9606">human</span>
Although other genes are known to exhibit species-specific splicing patterns (51-57), it is somewhat surprising that a gene very well conserved in evolution like the p53 gene displays such behavior (58). In addition, a closely related member of the p53 gene family, named p63, shows a complex pattern of alternative splicing in both the C- and N-terminal regions which, unlike the p53 gene, is conserved between the mouse and human genes (27).
###end p 62
###begin title 63
Analysis of the relative frequency of utilization of p53 alternative 3' splice sites from different species by transient transfection
###end title 63
###begin p 64
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1284 1287 1284 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1535 1540 1535 1540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1669 1672 1669 1672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 4 7 <span type="species:ncbi:10116">rat</span>
###xml 150 156 <span type="species:ncbi:10090">murine</span>
###xml 205 208 <span type="species:ncbi:10116">rat</span>
###xml 247 250 <span type="species:ncbi:10116">rat</span>
###xml 303 306 <span type="species:ncbi:10116">rat</span>
###xml 362 367 <span type="species:ncbi:10090">mouse</span>
###xml 403 406 <span type="species:ncbi:10116">rat</span>
###xml 430 433 <span type="species:ncbi:10116">rat</span>
###xml 542 545 <span type="species:ncbi:10116">rat</span>
###xml 678 681 <span type="species:ncbi:10116">rat</span>
###xml 1094 1097 <span type="species:ncbi:10116">rat</span>
###xml 1249 1252 <span type="species:ncbi:10116">rat</span>
###xml 1327 1333 <span type="species:ncbi:10090">murine</span>
###xml 1338 1341 <span type="species:ncbi:10116">rat</span>
###xml 1422 1425 <span type="species:ncbi:10116">rat</span>
###xml 1707 1710 <span type="species:ncbi:10116">rat</span>
The rat p53 gene has all the cis-acting sequences required for efficient use of the Cas 3' splice site because it is readily used when expressed in a murine cell line. In fact, relatively large amounts of rat p53Cas mRNA were also made in the NRK rat cell line expressing high levels of the transfected rat p53 minigene. We also observed good utilization of the mouse p53Cas 3' splice site in the NBTII rat cell line. Because the rat NBTII and NRK cell lines normally produce small amounts of endogenous p53Cas mRNA, our results suggest that rat cells may contain a factor that prevents use of the endogenous p53Cas 3' splice site. We propose that the better utilization of the rat Cas 3' splice site in this situation may be due to a larger amount of RNA produced in the transfections compared to endogenous levels. The excess of pre-mRNA might deregulate the splicing machinery, possibly by titrating a limiting or a negatively acting splicing factor, thereby leading to higher levels of alternatively spliced transcripts. Although these results indicate that the levels of expression of the rat p53 pre-mRNA we have obtained are not physiological, since regulation of alternative 3' splice site selection is lost, they nevertheless show that the rat p53 gene has all the necessary cis-acting sequences to be spliced in both murine and rat cells. Thus, the lack of utilization of the endogenous p53Cas 3' splice site in rat cell lines cannot be attributed to intrinsically poor consensus 5' and 3' splicing signals or to the lack of trans-acting splicing factors needed to recognize and utilize this 3' splice site. These results do not rule out the possibility that cis-acting sequences contained in the rat p53 minigene are involved in splice site selection.
###end p 64
###begin p 65
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 95 98 <span type="species:ncbi:10116">rat</span>
###xml 157 162 <span type="species:ncbi:10090">mouse</span>
###xml 254 257 <span type="species:ncbi:10116">rat</span>
###xml 262 267 <span type="species:ncbi:10090">mouse</span>
###xml 347 352 <span type="species:ncbi:10090">mouse</span>
###xml 415 418 <span type="species:ncbi:10116">rat</span>
###xml 427 432 <span type="species:ncbi:10090">mouse</span>
###xml 674 677 <span type="species:ncbi:10116">rat</span>
###xml 717 723 <span type="species:ncbi:10090">murine</span>
Indeed, it is possible that cis-acting elements such as a splicing silencer are present in the rat p53 gene, but have a weaker activity or are absent in the mouse p53 gene. Alternatively, it is possible that a splicing silencer is functional in both the rat and mouse p53 genes but that the levels of a factor recognizing this element is lower in mouse cells. Further experiments with hybrid constructs between the rat and the mouse p53 minigenes should help to map and identify such putative control elements. The presence of this type of regulatory element in intron 10 of the p53 gene would be consistent with a titratable factor negatively regulating utilization of the rat p53Cas 3' splice site and possibly the murine p53Cas 3' splice site.
###end p 65
###begin p 66
###xml 494 495 494 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f5">5</xref>
###xml 796 797 796 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd249f5">5</xref>
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 109 115 <span type="species:ncbi:10090">murine</span>
###xml 154 159 <span type="species:ncbi:9606">human</span>
###xml 253 259 <span type="species:ncbi:10090">murine</span>
###xml 326 331 <span type="species:ncbi:9606">human</span>
###xml 347 352 <span type="species:ncbi:10090">mouse</span>
###xml 445 450 <span type="species:ncbi:9606">human</span>
###xml 556 561 <span type="species:ncbi:9606">human</span>
###xml 581 584 <span type="species:ncbi:10116">rat</span>
###xml 676 681 <span type="species:ncbi:9606">human</span>
###xml 753 758 <span type="species:ncbi:10090">mouse</span>
###xml 763 766 <span type="species:ncbi:10116">rat</span>
###xml 897 902 <span type="species:ncbi:9606">human</span>
###xml 1061 1066 <span type="species:ncbi:9606">human</span>
###xml 1115 1120 <span type="species:ncbi:9606">human</span>
###xml 1382 1387 <span type="species:ncbi:9606">human</span>
###xml 1392 1397 <span type="species:ncbi:10090">mouse</span>
The observation that the human Panc cell line can produce an easily detectable level of p53Cas mRNA from the murine expression vector indicates that this human cell line has all the necessary splicing factors to generate p53Cas mRNA from a heterologous murine p53 pre-mRNA. We have been unable to detect the production of any human p53Cas mRNA in mouse cells in spite of the fact that we readily detected p53R mRNA produced from the transfected human p53 expression vector in these cells (Fig. 5). Also, we have been unable to detect the production of any human p53Cas mRNA in the rat NBTII cell line (data not shown), which is capable of producing large amounts of exogenous human p53R and easily detectable amounts of p53Cas mRNA from the transfected mouse and rat p53 expression vectors (Fig. 5C, lanes 2 and 4). In conjunction with the DNA sequencing data, these results are consistent with a human p53Cas splice site that is intrinsically weak or non-functional. Our results cannot rule out the presence of a very strong negative regulatory element in the human p53 splicing unit inhibiting utilization of the human p53Cas mRNA in its natural context. Although such an element could overwhelm the titration effect observed when large amounts of pre-mRNA are produced by transient transfection assays, this interpretation seems less likely. Again, hybrid constructs between the human and mouse p53 alternative splicing units should help resolve this issue.
###end p 66
###begin p 67
###xml 188 193 <span type="species:ncbi:9606">human</span>
###xml 198 201 <span type="species:ncbi:10116">rat</span>
###xml 323 326 <span type="species:ncbi:10116">rat</span>
###xml 415 420 <span type="species:ncbi:9606">human</span>
Taken together, our results indicate that the mechanism of alternative splice site selection in the C-terminal region of the p53 gene varies according to the species and that although the human and rat p53 genes produce low or undetectable levels of p53Cas mRNA they seem to reach that goal by different means. Whereas the rat p53Cas 3' splice site is functional, but possibly repressed by a titratable factor, the human p53Cas 3' splice site appears to be intrinsically weak or non-functional.
###end p 67
###begin p 68
###xml 259 264 256 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 281 283 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c59">59</xref>
###xml 647 649 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c57">57</xref>
###xml 86 89 <span type="species:ncbi:10116">rat</span>
###xml 129 136 <span type="species:ncbi:9031">chicken</span>
###xml 427 430 <span type="species:ncbi:10116">rat</span>
###xml 435 442 <span type="species:ncbi:9031">chicken</span>
It has been reported that splicing regulation of the alternative exon 6A is lost when rat recipient cells are transfected with a chicken beta-tropomyosin minigene, suggesting that the process of inclusion of alternative exons involves regulatory elements and trans-acting factors (59). In another study, the same group also reported that the differences in splicing regulation of the beta-tropomyosin gene observed between the rat and chicken genes could be attributed to differences in the nucleotide sequences at the 5' splice site, in the composition of the polypyrimidine tract and to the presence of an intronic splicing enhancer in exon 6A (57). These results are consistent with our observations and with the presence of other putative splicing regulatory elements that may be overridden by overexpression of the pre-mRNA during a transient transfection assay.
###end p 68
###begin p 69
###xml 51 54 51 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd249c60">60</xref>
###xml 360 363 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 385 390 385 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 483 488 <span type="species:ncbi:10090">mouse</span>
###xml 490 493 <span type="species:ncbi:10116">rat</span>
###xml 498 503 <span type="species:ncbi:9606">human</span>
Our results also indicate the presence of negative cis-acting regulatory sequences in the p53 minigene that may be recognized by a titratable factor. A similar titration effect leading to lack of regulation in the inclusion of exon IIIb of the FGF-R2 receptor was recently described and is consistent the interpretation of our data (60). Identification of the cis-acting sequences and trans-acting factors responsible for the differences observed in the splicing pattern between the mouse, rat and human p53 genes will help to further clarify the mechanisms affecting splice site selection.
###end p 69
###begin title 70
Figures and Tables
###end title 70
###begin p 71
###xml 57 58 57 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 116 117 116 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
 Alternative splicing of the p53 tumor suppressor gene. (A) Diagrammatic representation of the p53 gene structure. (B) Alternative splicing pattern in the C-terminal region of the p53 gene with two alternative 3' splice sites (3'Cas and 3'Reg) in intron 10.
###end p 71
###begin p 72
###xml 45 46 45 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 451 452 451 452 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 746 747 746 747 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 157 162 <span type="species:ncbi:10090">mouse</span>
###xml 177 182 <span type="species:ncbi:9606">human</span>
###xml 939 944 <span type="species:ncbi:10090">mouse</span>
###xml 958 961 <span type="species:ncbi:10116">rat</span>
###xml 1006 1011 <span type="species:ncbi:9606">human</span>
 Analysis of p53 mRNA levels in cell lines. (A) Analysis of expression of the p53Cas and p53Reg mRNAs in different cell lines by RNase protection assay. The mouse (MT7C-E9) and human (H7E-PuI) probes used are depicted schematically (see Materials and Methods). The sizes of the protected fragments in nucleotides are indicated in parentheses. The 169 nt band located just above the p53Cas protected fragment (166 nt) represents the undigested probe. (B) Analysis of expression of the p53Cas and p53R mRNAs in different cell lines by RT-PCR. The identity of the amplified PCR fragment corresponding to the two p53 isoforms is indicated. The band located between the p53Cas and the p53R bands in some lanes corresponds to a spurious PCR artifact. (C) Diagrammatic representation of the p53 oligonucleotides used in the RT-PCR analysis shown above. Reverse transcription of cytoplasmic RNA was done using the E11A7 oligonucleotide primer for mouse, hamster and rat RNA or the MPuA2 oligonucleotide primer for human and monkey RNA. PCR amplification was performed using the primers E10S1 and MPuA2.
###end p 72
###begin p 73
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
###xml 101 106 <span type="species:ncbi:9606">human</span>
###xml 108 111 <span type="species:ncbi:10116">rat</span>
 Diagrammatic representation of the PCR amplification products used for DNA sequencing of the mouse, human, rat and hamster p53 exon 10-exon 11 region. The p53-specific oligonucleotides are indicated by arrows. The sizes of the PCR amplification products are shown below the oligonucleotides.
###end p 73
###begin p 74
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
###xml 34 37 <span type="species:ncbi:10116">rat</span>
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 46 53 <span type="species:ncbi:499232|species:ncbi:9593">gorilla</span>
###xml 173 178 <span type="species:ncbi:9606">human</span>
 Sequence alignment of the mouse, rat, human, gorilla and hamster p53 exon 10-exon 11 region. To facilitate the alignment, sequences corresponding to the Alu element in the human p53 gene were deleted (Hp53DeltaAlu). The 5' splice site (5'SS), the alternative 3' splice site (3'Cas) and the regular 3' splice site (3'Reg) are indicated. The consensus GT dinucleotide at the 5' splice site and the consensus AG dinucleotide at the 3' splice sites are shown in lower case.
###end p 74
###begin p 75
###xml 168 169 168 169 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 532 533 532 533 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 832 833 832 833 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
###xml 77 80 <span type="species:ncbi:10116">rat</span>
###xml 85 90 <span type="species:ncbi:9606">human</span>
###xml 191 197 <span type="species:ncbi:10090">murine</span>
###xml 231 237 <span type="species:ncbi:10090">murine</span>
###xml 248 251 <span type="species:ncbi:10116">rat</span>
###xml 264 269 <span type="species:ncbi:9606">human</span>
###xml 303 308 <span type="species:ncbi:10090">mouse</span>
###xml 355 360 <span type="species:ncbi:9606">human</span>
###xml 555 560 <span type="species:ncbi:9606">human</span>
###xml 594 600 <span type="species:ncbi:10090">murine</span>
###xml 633 638 <span type="species:ncbi:10090">mouse</span>
###xml 855 858 <span type="species:ncbi:10116">rat</span>
###xml 899 904 <span type="species:ncbi:10090">mouse</span>
###xml 914 917 <span type="species:ncbi:10116">rat</span>
###xml 991 996 <span type="species:ncbi:10090">mouse</span>
###xml 1054 1057 <span type="species:ncbi:10116">rat</span>
 RNase protection analysis of the alternative splicing pattern of the mouse, rat and human p53 gene in cell lines from different species after transient transfection. (A) Transfection of the murine neuroblastoma N2A cell line with murine p53 (Mp), rat p53 (Rp) or human p53 (Hp) expression vectors. The mouse p53 probe Mp53L was used in lanes 1-4 and the human p53 probe Hp53B was used in lane 5 (see Materials and Methods). C, control (non-transfected cell line); Exo, exogenous (transfected) p53 mRNA; Endo, endogenous p53 mRNA. (B) Transfection of the human Panc and N2A cell lines with the murine p53 expression vector (Mp). The mouse p53 cDNA probe MT7E-E9 is shown schematically. The protected fragments corresponding to the transfected (p53R Exo and p53C Exo) products are indicated. C, control (non-transfected cell line). (C) Transfection of the rat cell lines NBTII (NBT) and NRK with the mouse (Mp) and rat (Rp) p53 expression vectors. RNA in lanes 1 and 2 was protected with the mouse probe Mp53L. RNA in lanes 3 and 4 was protected with the rat p53 probe Rp53L (see Materials and Methods). Additional bands correspond to incomplete RNase digestion products.
###end p 75
###begin title 76
Cell lines tested for alternative splicing in the C-terminal region of p53 between exons 10 and 11
###end title 76
###begin p 77
+, detected; +/-, low to very low levels; -, not detected.
###end p 77
###begin p 78
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aTested by RNase protection.
###end p 78
###begin p 79
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
bTested by RT-PCR.
###end p 79
###begin title 80
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
###xml 32 35 <span type="species:ncbi:10116">rat</span>
###xml 40 45 <span type="species:ncbi:9606">human</span>
Size of intron 10 in the mouse, rat and human p53 gene
###end title 80
###begin title 81
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
###xml 52 55 <span type="species:ncbi:10116">rat</span>
###xml 60 65 <span type="species:ncbi:9606">human</span>
Percentage of homology in intron 10 from the mouse, rat and human p53 gene
###end title 81
###begin title 82
ACKNOWLEDGEMENTS
###end title 82
###begin p 83
We are grateful to Drs B. Chabot and D. Gibson for comments on the manuscript. This work was supported by a grant from the National Sciences and Engineering Research Council of Canada. A.L. was supported by a scholarship from the Fonds de Recherches en Sante du Quebec. M.L. is supported by a studentship from the Fonds pour la Formation de Chercheurs et l'Aide a la Recherche.
###end p 83
###begin title 84
REFERENCES
###end title 84

